Active placebo control groups of pharmacological interventions were rarely used but merited serious consideration: a methodological overview-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Active placebo control groups of pharmacological interventions were rarely used but merited serious consideration: a methodological overview

Published:2017-07 Issue: Volume:87 Page:35-46
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Jensen Jakob Solgaard,Bielefeldt Andreas Ørsted^ORCID,Hróbjartsson Asbjørn

Publisher

Elsevier BV

Subject

Epidemiology

Reference51 articles.

1. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies;Hrobjartsson;Int J Epidemiol,2014

2. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors;Hróbjartsson;BMJ,2012

3. The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publications;Bello;J Clin Epidemiol,2014

4. Double-blindness procedures, rater blindness, and ratings of outcome. Observations from a controlled trial;Başoğlu;Arch Gen Psychiatry,1997

5. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials;Bystritsky;J Nerv Ment Dis,1994

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nettle-induced Urticaria Treatment Study (NUTS): demonstrating the joy of research through a randomised, blinded, placebo-controlled trial;Emergency Medicine Journal;2024-07-29

2. Side-effects are often a curse. Can they also be a blessing?;Brain;2024-07-11

3. How side effects can improve treatment efficacy: a randomized trial;Brain;2024-05-03

4. 2 Clinical Research on Infectious Diseases: An Overview;Principles and Practice of Emergency Research Response;2024

5. How side effects can improve treatment efficacy: a randomized trial;2023-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3